<![CDATA[Screening for CHIP Mutations to Guide CAR T Cell Candidacy in Lymphoma]]>

Summary

Dr. Jasmine Zain discusses how screening for CHIP mutations should inform pre-infusion risk counseling and CAR T cell treatment selection in lymphoma patients. This represents a clinical guidance recommendation based on mutation screening.